Assessment of the Efficacy of the Aerodentis System
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jan 29, 2018
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
The Aerodentis system is intended for the treatment of tooth malocclusion and is treated by applying force, over time, to teeth requiring alignment. Traditionally, the force has been created by attaching brackets to the teeth and creating tension through the stretching of flexible wire connected between the brackets. Alternatively, aligners are used for the treatment of tooth malocclusion. In these devices, a series of mouthpieces are used, where the force created by each mouthpiece on the treated teeth is designed to push the teeth in small, one step increments, toward the desired result.T...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Permanent dentition
- • Patients that in the opinion of the investigator will be compliant with device use. Compliance is determined by patient questionnaire.
- • Class I malocclusion with crowding of \<6 mm between the anterior teeth from the right first premolar to the left first premolar, on the upper and lower.
- • Good oral hygiene, as determined by investigator orthodontist.
- Exclusion Criteria:
- • Any medical or dental condition that, in the opinion of the investigator, could negatively affect study results during the expected length of the study. Conditions can include poor oral hygiene, extensive dental treatments, or periodontal disease.
- • Patient is currently using any investigational drug or any other investigational device.
- • Patient plans to relocate or move during the treatment period.
- • Pregnant females. Orthodontic treatment is not advised in pregnant females.
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Chung How Kau, BDS, PhD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials